颅内动脉粥样硬化与脑β-淀粉样蛋白沉积的关联:ARIC研究二次分析
该研究基于美国3个社区的ARIC-PET队列,纳入300例70-90岁无痴呆成人,采用高分辨血管壁MRI评估颅内动脉粥样硬化(ICAD),以florbetapir PET评估脑β-淀粉样蛋白沉积。横断面分析显示,ICAD存在或狭窄均与全局皮质SUVR>1.2无显著关联。
要点
- 在无痴呆老年人中,ICAD斑块存在或狭窄与脑β-淀粉样蛋白沉积无显著关联。
- ICAD与认知障碍的关联机制可能不主要通过阿尔茨海默病病理途径。
核心结论
- 在无痴呆的社区老年人中,颅内动脉粥样硬化斑块或狭窄与脑β-淀粉样蛋白沉积无显著关联。
研究设计与样本
- 横断面分析,数据收集于2011年8月至2014年11月,来自美国3个社区的ARIC研究。
- 从ARIC-PET研究中连续招募70-90岁无痴呆成人,共300例符合纳入标准。
- 暴露为高分辨血管壁MRI评估的ICAD存在、频率和狭窄程度;结局为florbetapir PET全局皮质SUVR>1.2。
主要发现
- 300例参与者平均年龄76岁(SD 5),44%为非裔美国人,56%为女性,31%携带至少1个APOE ε4等位基因。
- 调整模型中,ICAD存在(aOR 1.20,95%CI 0.69-2.07)和频率(aOR 1.10,95%CI 0.96-1.26)与SUVR升高无显著关联。
- 颅内血管中度狭窄(>50%)与SUVR升高无显著关联(aOR 2.33,95%CI 0.82-6.60)。
临床怎么用
- 对于无痴呆老年人,ICAD的存在或狭窄不提示需针对脑β-淀粉样蛋白沉积进行额外评估。
- ICAD与认知障碍的关联机制可能不主要通过阿尔茨海默病病理途径,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Intracranial atherosclerotic disease (ICAD) is an important cause of stroke and has also been recently identified as an important risk factor for all-cause dementia, but the mechanism of its association with cognitive performance is not fully understood. OBJECTIVE: To test the hypothesis that ICAD is associated with cerebral β-amyloid deposition as a marker of Alzheimer disease. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of data collected from August 2011 through November 2014 was a community-based cohort study conducted in 3 US communities. Of 346 adults without dementia aged 70 to 90 years who were sequentially recruited from 3 of 4 sites of the larger Atherosclerosis Risk in Communities study into a study of brain florbetapir positron emission tomography (ARIC-PET), 300 met inclusion criteria. A total of 589 were approached about recruitment, of whom 346 (58.7%) consented (the remainder either met exclusion criteria for ARIC-PET or refused to participate). Data were analyzed from July 2017 through October 2019. EXPOSURES: Intracranial atherosclerotic disease presence, frequency, and extent of stenosis, by high-resolution vessel wall magnetic resonance imaging. MAIN OUTCOMES AND MEASURES: Global cortical standardized uptake value ratio (SUVR) of greater than 1.2 as measured by florbetapir PET. Models were conducted using logistic regression methods. In secondary analyses, we tested effect modifications by apolipoprotein E ε4 genotype with interaction terms and in stratified models and evaluated regional patterns of associations. RESULTS: In 300 participants (mean [SD] age, 76 [5] years; 132 African American individuals [44%], 167 women [56%], and 94 carriers of at least 1 apolipoprotein E ε4 allele [31%]), ICAD was found in 105 participants (35%) and mean (SD) SUVR was higher in individuals with vs without intracranial plaques (1.34 [0.29] vs 1.27 [0.23]; P = .03). In adjusted models, ICAD presence (plaque presence [adjusted odds ratio (aOR), 1.20; 95% CI, 0.69-2.07] and frequency [aOR, 1.10; 95% CI, 0.96-1.26]) was not associated significantly with elevated SUVR in the total sample. Furthermore, modest stenosis of the intracranial vessels (defined as >50% stenosis) was not associated with elevated SUVR (aOR, 2.33; 95% CI, 0.82-6.60). CONCLUSIONS AND RELEVANCE: In this community-based cohort of adults without dementia, intracranial atherosclerotic plaque or stenosis was not associated with brain β-amyloid deposition.
引用
- Gottesman RF, Mosley TH, Knopman DS, et al. Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study. JAMA Neurol. 2020. PMID: 31860001. doi:10.1001/jamaneurol.2019.4339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。